Initiate study of anti-depressant generic drug switches with Company X2 <br>This key project has been retired as CDER has created new measures and key projects for FY13 which align to their four functional areas of 1) Regulatory Review and Drug Safety, 2) Drug Quality and Compliance, 3) Transparency and Public Outreach, and 4) Regulatory Science Research. </b> ON HOLDON TRACK1. Finalize protocol11/1/2009Completed11/30/20092. Initiate study4/1/2010Completed4/1/20103. Complete study (1)7/1/2011Delayed4. Release study report11/1/2012Delayed(1) Completion of study will depend on ability to adequately recruit appropriate patientshttp://www.fda.gov/AboutFDA/Transparency/track/ucm206444.htmFDA-TRACK CDER Dashboard ਍††਍਍਍਍਍਍਍